Axiom Exhibiting at DIA 2021 Global Annual Meeting and Virtual Conference June 27- July 1, 2021
TORONTO, June 25, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused...
News
22nd Century Group Provides Business Update from CEO Detailing Company Progress Over Past Year and Future Initiatives
BUFFALO, N.Y., June 25, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company...
Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease
TOKYO, June 25, 2021 (GLOBE NEWSWIRE) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and FibroGen,...
NervGen Engages Vorticom Inc. to Provide Media Relations Services
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
The Hub Craft and “The Glove” Gary Payton will be launching Payton’s Place in Massachusetts
The Hub Craft proudly collaborates with Gary Payton to manufacture Cannabis products for statewide distribution in Massachusetts.Fitchburg, Massachusetts--(Newsfile Corp. -...
ESO Signs Definitive Agreement to Acquire Emergency Reporting, Leading Fire Records Management System (RMS)
Company brings fire service breadth and depth to ESO’s extensive health and safety ecosystem AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading data...
Neutra’s New Deity Wellness Subsidiary Off to Roaring Start with Delta-8 Pre-Sales
KATY, TX / ACCESSWIRE / June 25, 2021 / Neutra Corp. (OTC PINK:NTRR) reports its wholly-owned Deity Wellness (www.deitywellness.com) subsidiary,...
Perspectum Files Registration Statement for Proposed Initial Public Offering
OXFORD, England--(BUSINESS WIRE)--Perspectum, a commercial-stage, precision-health company developing proprietary digital technologies that enable clinicians to more accurately diagnose and monitor...
AgriCann Solutions to Acquire Businesses for Shares
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2021) - AgriCann Solutions Corp. (the "Company", "AgriCann" or "ASC") is pleased to...
Ascom Expands Unite Software Ecosystem With Launch of Unite Collaborate Application
MORRISVILLE, N.C.--(BUSINESS WIRE)--Ascom, a global solutions provider focused on healthcare ICT and mobile workflows, is expanding its Ascom Unite software...
Michael Monson Appointed Chief Executive Officer and President of Altarum by Board of Trustees
WASHINGTON--(BUSINESS WIRE)--The Altarum Board of Trustees has selected Michael Monson, a former executive of the nation’s largest Medicaid managed care...
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
If approved, tafasitamab in combination with lenalidomide would represent an important new therapeutic option for eligible DLBCL patients in the...
LaunchPad Café Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA)
LaunchPad Café Ltd. Announces Closing of Transaction with Ventana Biotech, Inc. (VNTA) LaunchPad Café Ltd. announces that it has closed...
Y-mAbs’ 177Lu-omburtamab-DTPA for the Treatment of Patients with Medulloblastoma Receives Positive Opinion on Orphan Medicinal Product Designation by EMA
NEW YORK, June 25, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021
– Results demonstrate positive safety profiles and a reduction in HBsAg for two novel HBV therapies administrated as monotherapy or in...
Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate Cancer
--Sabizabulin is a novel oral androgen receptor transport disruptor---- In Phase 1b/2 clinical study, sabizabulin was well tolerated with significant...
Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors
Scott Mendel Diagnostics industry leader Scott Mendel is appointed to Akoya's Board of Directors. MARLBOROUGH, Mass., June 25, 2021 (GLOBE...
BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
Chairman Terren Peizer discusses BioVie’s late-stage drug pipeline with multiple shots on goalSANTA MONICA, Calif., June 25, 2021 (GLOBE NEWSWIRE)...
Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043
Company to advance SZN-043 toward first-in-human clinical studies in 2022SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- Surrozen...
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions
THE WOODLANDS, Texas, June 25, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be a...